Organon & Co.
Organon & Co. OGN Peers
See (OGN) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - General Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| OGN | $9.96 | -1.87% | 2.6B | 3.46 | $2.88 | +8.63% |
| LLY | $780.67 | +0.18% | 739.9B | 63.73 | $12.25 | +0.72% |
| AZN | $69.45 | -2.36% | 430.6B | 28.00 | $2.48 | +2.22% |
| JNJ | $156.01 | +0.29% | 375.4B | 17.35 | $8.99 | +3.22% |
| ABBV | $189.28 | -0.77% | 334.3B | 81.24 | $2.33 | +3.37% |
| NVO | $69.17 | -0.93% | 306.3B | 19.06 | $3.63 | +2.33% |
| NVS | $121.90 | -1.54% | 240.8B | 19.11 | $6.38 | +3.28% |
| MRK | $80.93 | -1.77% | 203.2B | 11.76 | $6.88 | +3.95% |
| AMGN | $298.24 | +0.47% | 160.4B | 27.16 | $10.98 | +3.10% |
| PFE | $25.38 | +0.24% | 144.3B | 18.39 | $1.38 | +6.70% |
Stock Comparison
OGN vs LLY Comparison
OGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OGN stands at 2.6B. In comparison, LLY has a market cap of 739.9B. Regarding current trading prices, OGN is priced at $9.96, while LLY trades at $780.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OGN currently has a P/E ratio of 3.46, whereas LLY's P/E ratio is 63.73. In terms of profitability, OGN's ROE is +1.82%, compared to LLY's ROE of +0.77%. Regarding short-term risk, OGN is more volatile compared to LLY. This indicates potentially higher risk in terms of short-term price fluctuations for OGN.
OGN vs AZN Comparison
OGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OGN stands at 2.6B. In comparison, AZN has a market cap of 430.6B. Regarding current trading prices, OGN is priced at $9.96, while AZN trades at $69.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OGN currently has a P/E ratio of 3.46, whereas AZN's P/E ratio is 28.00. In terms of profitability, OGN's ROE is +1.82%, compared to AZN's ROE of +0.19%. Regarding short-term risk, OGN is less volatile compared to AZN. This indicates potentially lower risk in terms of short-term price fluctuations for OGN.
OGN vs JNJ Comparison
OGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OGN stands at 2.6B. In comparison, JNJ has a market cap of 375.4B. Regarding current trading prices, OGN is priced at $9.96, while JNJ trades at $156.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OGN currently has a P/E ratio of 3.46, whereas JNJ's P/E ratio is 17.35. In terms of profitability, OGN's ROE is +1.82%, compared to JNJ's ROE of +0.30%. Regarding short-term risk, OGN is more volatile compared to JNJ. This indicates potentially higher risk in terms of short-term price fluctuations for OGN.
OGN vs ABBV Comparison
OGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OGN stands at 2.6B. In comparison, ABBV has a market cap of 334.3B. Regarding current trading prices, OGN is priced at $9.96, while ABBV trades at $189.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OGN currently has a P/E ratio of 3.46, whereas ABBV's P/E ratio is 81.24. In terms of profitability, OGN's ROE is +1.82%, compared to ABBV's ROE of +0.96%. Regarding short-term risk, OGN is more volatile compared to ABBV. This indicates potentially higher risk in terms of short-term price fluctuations for OGN.
OGN vs NVO Comparison
OGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OGN stands at 2.6B. In comparison, NVO has a market cap of 306.3B. Regarding current trading prices, OGN is priced at $9.96, while NVO trades at $69.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OGN currently has a P/E ratio of 3.46, whereas NVO's P/E ratio is 19.06. In terms of profitability, OGN's ROE is +1.82%, compared to NVO's ROE of +0.81%. Regarding short-term risk, OGN is more volatile compared to NVO. This indicates potentially higher risk in terms of short-term price fluctuations for OGN.
OGN vs NVS Comparison
OGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OGN stands at 2.6B. In comparison, NVS has a market cap of 240.8B. Regarding current trading prices, OGN is priced at $9.96, while NVS trades at $121.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OGN currently has a P/E ratio of 3.46, whereas NVS's P/E ratio is 19.11. In terms of profitability, OGN's ROE is +1.82%, compared to NVS's ROE of +0.31%. Regarding short-term risk, OGN is more volatile compared to NVS. This indicates potentially higher risk in terms of short-term price fluctuations for OGN.
OGN vs MRK Comparison
OGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OGN stands at 2.6B. In comparison, MRK has a market cap of 203.2B. Regarding current trading prices, OGN is priced at $9.96, while MRK trades at $80.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OGN currently has a P/E ratio of 3.46, whereas MRK's P/E ratio is 11.76. In terms of profitability, OGN's ROE is +1.82%, compared to MRK's ROE of +0.38%. Regarding short-term risk, OGN is more volatile compared to MRK. This indicates potentially higher risk in terms of short-term price fluctuations for OGN.
OGN vs AMGN Comparison
OGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OGN stands at 2.6B. In comparison, AMGN has a market cap of 160.4B. Regarding current trading prices, OGN is priced at $9.96, while AMGN trades at $298.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OGN currently has a P/E ratio of 3.46, whereas AMGN's P/E ratio is 27.16. In terms of profitability, OGN's ROE is +1.82%, compared to AMGN's ROE of +0.93%. Regarding short-term risk, OGN is more volatile compared to AMGN. This indicates potentially higher risk in terms of short-term price fluctuations for OGN.
OGN vs PFE Comparison
OGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OGN stands at 2.6B. In comparison, PFE has a market cap of 144.3B. Regarding current trading prices, OGN is priced at $9.96, while PFE trades at $25.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OGN currently has a P/E ratio of 3.46, whereas PFE's P/E ratio is 18.39. In terms of profitability, OGN's ROE is +1.82%, compared to PFE's ROE of +0.09%. Regarding short-term risk, OGN is more volatile compared to PFE. This indicates potentially higher risk in terms of short-term price fluctuations for OGN.
OGN vs GILD Comparison
OGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OGN stands at 2.6B. In comparison, GILD has a market cap of 139B. Regarding current trading prices, OGN is priced at $9.96, while GILD trades at $111.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OGN currently has a P/E ratio of 3.46, whereas GILD's P/E ratio is 14.44. In terms of profitability, OGN's ROE is +1.82%, compared to GILD's ROE of +0.32%. Regarding short-term risk, OGN is more volatile compared to GILD. This indicates potentially higher risk in terms of short-term price fluctuations for OGN.
OGN vs SNY Comparison
OGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OGN stands at 2.6B. In comparison, SNY has a market cap of 117.7B. Regarding current trading prices, OGN is priced at $9.96, while SNY trades at $48.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OGN currently has a P/E ratio of 3.46, whereas SNY's P/E ratio is 16.66. In terms of profitability, OGN's ROE is +1.82%, compared to SNY's ROE of +0.08%. Regarding short-term risk, OGN is more volatile compared to SNY. This indicates potentially higher risk in terms of short-term price fluctuations for OGN.
OGN vs CELG-RI Comparison
OGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OGN stands at 2.6B. In comparison, CELG-RI has a market cap of 96.9B. Regarding current trading prices, OGN is priced at $9.96, while CELG-RI trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OGN currently has a P/E ratio of 3.46, whereas CELG-RI's P/E ratio is N/A. In terms of profitability, OGN's ROE is +1.82%, compared to CELG-RI's ROE of +0.32%. Regarding short-term risk, OGN is more volatile compared to CELG-RI. This indicates potentially higher risk in terms of short-term price fluctuations for OGN.
OGN vs BMY Comparison
OGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OGN stands at 2.6B. In comparison, BMY has a market cap of 95.5B. Regarding current trading prices, OGN is priced at $9.96, while BMY trades at $46.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OGN currently has a P/E ratio of 3.46, whereas BMY's P/E ratio is 17.51. In terms of profitability, OGN's ROE is +1.82%, compared to BMY's ROE of +0.32%. Regarding short-term risk, OGN is more volatile compared to BMY. This indicates potentially higher risk in terms of short-term price fluctuations for OGN.
OGN vs GSK Comparison
OGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OGN stands at 2.6B. In comparison, GSK has a market cap of 78.2B. Regarding current trading prices, OGN is priced at $9.96, while GSK trades at $38.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OGN currently has a P/E ratio of 3.46, whereas GSK's P/E ratio is 18.72. In terms of profitability, OGN's ROE is +1.82%, compared to GSK's ROE of +0.22%. Regarding short-term risk, OGN is more volatile compared to GSK. This indicates potentially higher risk in terms of short-term price fluctuations for OGN.
OGN vs HZNP Comparison
OGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OGN stands at 2.6B. In comparison, HZNP has a market cap of 26.6B. Regarding current trading prices, OGN is priced at $9.96, while HZNP trades at $116.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OGN currently has a P/E ratio of 3.46, whereas HZNP's P/E ratio is 61.86. In terms of profitability, OGN's ROE is +1.82%, compared to HZNP's ROE of +0.11%. Regarding short-term risk, OGN is more volatile compared to HZNP. This indicates potentially higher risk in terms of short-term price fluctuations for OGN.
OGN vs BIIB Comparison
OGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OGN stands at 2.6B. In comparison, BIIB has a market cap of 19.5B. Regarding current trading prices, OGN is priced at $9.96, while BIIB trades at $132.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OGN currently has a P/E ratio of 3.46, whereas BIIB's P/E ratio is 13.13. In terms of profitability, OGN's ROE is +1.82%, compared to BIIB's ROE of +0.09%. Regarding short-term risk, OGN is more volatile compared to BIIB. This indicates potentially higher risk in terms of short-term price fluctuations for OGN.
OGN vs GRFS Comparison
OGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OGN stands at 2.6B. In comparison, GRFS has a market cap of 7.6B. Regarding current trading prices, OGN is priced at $9.96, while GRFS trades at $9.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OGN currently has a P/E ratio of 3.46, whereas GRFS's P/E ratio is 33.63. In terms of profitability, OGN's ROE is +1.82%, compared to GRFS's ROE of +0.03%. Regarding short-term risk, OGN is more volatile compared to GRFS. This indicates potentially higher risk in terms of short-term price fluctuations for OGN.
OGN vs CTOR Comparison
OGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OGN stands at 2.6B. In comparison, CTOR has a market cap of 378.5M. Regarding current trading prices, OGN is priced at $9.96, while CTOR trades at $5.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OGN currently has a P/E ratio of 3.46, whereas CTOR's P/E ratio is -13.92. In terms of profitability, OGN's ROE is +1.82%, compared to CTOR's ROE of -0.15%. Regarding short-term risk, OGN is less volatile compared to CTOR. This indicates potentially lower risk in terms of short-term price fluctuations for OGN.
OGN vs SCLX Comparison
OGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OGN stands at 2.6B. In comparison, SCLX has a market cap of 44.2M. Regarding current trading prices, OGN is priced at $9.96, while SCLX trades at $6.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OGN currently has a P/E ratio of 3.46, whereas SCLX's P/E ratio is -0.42. In terms of profitability, OGN's ROE is +1.82%, compared to SCLX's ROE of +0.36%. Regarding short-term risk, OGN is less volatile compared to SCLX. This indicates potentially lower risk in terms of short-term price fluctuations for OGN.
OGN vs SCLXW Comparison
OGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OGN stands at 2.6B. In comparison, SCLXW has a market cap of 34.7M. Regarding current trading prices, OGN is priced at $9.96, while SCLXW trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OGN currently has a P/E ratio of 3.46, whereas SCLXW's P/E ratio is N/A. In terms of profitability, OGN's ROE is +1.82%, compared to SCLXW's ROE of +0.36%. Regarding short-term risk, OGN is less volatile compared to SCLXW. This indicates potentially lower risk in terms of short-term price fluctuations for OGN.
OGN vs MIRA Comparison
OGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OGN stands at 2.6B. In comparison, MIRA has a market cap of 20.9M. Regarding current trading prices, OGN is priced at $9.96, while MIRA trades at $1.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OGN currently has a P/E ratio of 3.46, whereas MIRA's P/E ratio is -2.55. In terms of profitability, OGN's ROE is +1.82%, compared to MIRA's ROE of -3.41%. Regarding short-term risk, OGN is less volatile compared to MIRA. This indicates potentially lower risk in terms of short-term price fluctuations for OGN.
OGN vs SRXH Comparison
OGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OGN stands at 2.6B. In comparison, SRXH has a market cap of 7.5M. Regarding current trading prices, OGN is priced at $9.96, while SRXH trades at $0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OGN currently has a P/E ratio of 3.46, whereas SRXH's P/E ratio is N/A. In terms of profitability, OGN's ROE is +1.82%, compared to SRXH's ROE of -0.50%. Regarding short-term risk, OGN is less volatile compared to SRXH. This indicates potentially lower risk in terms of short-term price fluctuations for OGN.
OGN vs CRXT Comparison
OGN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OGN stands at 2.6B. In comparison, CRXT has a market cap of 0. Regarding current trading prices, OGN is priced at $9.96, while CRXT trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OGN currently has a P/E ratio of 3.46, whereas CRXT's P/E ratio is -0.02. In terms of profitability, OGN's ROE is +1.82%, compared to CRXT's ROE of -4.63%. Regarding short-term risk, OGN is less volatile compared to CRXT. This indicates potentially lower risk in terms of short-term price fluctuations for OGN.